会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Nucleic acids encoding BDP-1
    • 编码BDP-1的核酸
    • US07074589B1
    • 2006-07-11
    • US08877150
    • 1997-06-17
    • Axel UllrichNaohito AokiYeong Woong KimHong Yang WangZhengjun ChenOliver NaylerAlexei Kharitonenkov
    • Axel UllrichNaohito AokiYeong Woong KimHong Yang WangZhengjun ChenOliver NaylerAlexei Kharitonenkov
    • C12P21/06
    • C12N9/1205A61K38/00C07K14/4703C07K16/18C07K16/40C12N9/16
    • Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for diseases related to PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptide or conditions characterized by an abnormal interaction between such a polypeptide and its binding partner.
    • 编码全长PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP多肽的核酸分子,这些核酸分子的部分,含有该核酸分子的核酸载体,含有该核酸载体的重组细胞,纯化的多肽 来自这样的重组细胞,对这些多肽的抗体,以及鉴定结合这些多肽的化合物或废除其与天然结合配偶体的相互作用的方法。 用于诊断具有PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP相关分子或化合物的生物体的异常状况的方法。 PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4或SIRP多肽,编码此类多肽的核酸,含有此类核酸的细胞,组织和动物,使用此类多肽的抗体,以及与所有这些多肽相关的方法 以上。 提供了与PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP多肽有关的疾病或特征为这种多肽与其结合配偶体之间异常相互作用的病症的治疗,诊断和筛选方法。
    • 6. 发明申请
    • Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods
    • 新型PTP-20,PCP-2,BDP1,CLK和SIRP蛋白及相关产品及方法
    • US20080051556A1
    • 2008-02-28
    • US11153918
    • 2005-06-16
    • Axel UllrichNaohito AokiYeong Woong KimHong Yang WangZhengjun ChenOliver NaylerAlexei Kharitonenkov
    • Axel UllrichNaohito AokiYeong Woong KimHong Yang WangZhengjun ChenOliver NaylerAlexei Kharitonenkov
    • C07K2/00C07H21/00C07K16/00
    • C12N9/1205A61K38/00C07K14/4703C07K16/18C07K16/40C12N9/16
    • Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that bind such polypeptides or abrogate their interactions with natural binding partners. Methods for diagnosing abnormal conditions in an organism with PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP related molecules or compounds. PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, or SIRP polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for diseases related to PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides or conditions characterized by an abnormal interaction between such a polypeptide and its binding partner.
    • 编码全长PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP多肽的核酸分子,这些核酸分子的部分,含有该核酸分子的核酸载体,含有该核酸载体的重组细胞,纯化的多肽 来自这样的重组细胞,对这些多肽的抗体,以及鉴定结合这些多肽的化合物或废除其与天然结合配偶体的相互作用的方法。 用于诊断具有PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP相关分子或化合物的生物体的异常状况的方法。 PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4或SIRP多肽,编码此类多肽的核酸,含有此类核酸的细胞,组织和动物,使用此类多肽的抗体,以及与所有这些多肽相关的方法 以上。 为与PTP20,PCP-2,BDP1,mCLK2,mCLK3,mCLK4和SIRP多肽相关的疾病或特征为这种多肽与其结合配偶体之间的异常相互作用的病症提供了治疗,诊断和筛选方法。